• كيمياء طبية
• تصميم أدوية
• تصميم الأشكال الصيدلية

• استخدام الأدوات الحاسوبية لاكتشاف وتصميم الجزيئات النشطة جديدة لعلاج مرض السكري

• Mohammed M Al-Mahadeen, Areej M Jaber, Belal O Al-Najjar, Monther A Khanfar, Mustafa M El-Abadelah (2025) Novel N-substituted Isatin-oxoindolin-1H-Benzo[D] Imidazole Fumarate as a New Class of JNK3 Inhibitor: Design, Synthesis, Molecular Modeling Current Organic Synthesis, 22,3, 410-418
• Hamdi Nsairat, Zainab Lafi, Belal O Al-Najjar, Ali Al-Samydai, Fadi G Saqallah, Mohamed El-Tanani, Ghaleb Ali Oriquat, Bailasan Mohammad Sa’bi, Abed Alqader Ibrahim, Anthony Lee Dellinger, Walhan Alshaer (2025) How Advanced are Self-Assembled Nanomaterials for Targeted Drug Delivery? A Comprehensive Review of the Literature International Journal of Nanomedicine, 2133-2161
• AM Jaber, MM Al-Mahadeen, BO Al-Najjar, RA Al-Qawasmeh (2025) Synthesis, molecular docking, and anti-inflam-matory evaluation of novel 4-(benzo [d][1, 3] dioxol-5-yloxy)-N, N-2-yn-1-amine derivatives as potent cysteinyl leukotriene Pharmacia, 2025
• Belal O Al-Najjar, Muath Helal, Fadi G Saqallah, B Bandy (2025) Isozyme specific inhibition of GSTP1-1; A crucial element in cancer targeting drugs RSC Medicinal Chemistry, 0
• Belal O Al-Najjar, Fatma Elshibani, Mohamed A Sharkasi, Nouha El Shintiri, Esra El Naili, Munira Abdulsayid, Roya S Abozayed, Hamdoon A Mohammed (2025) Phytochemical analysis, bioactivity, and molecular docking studies of Myrtus communis L. seeds and fruit peel extracts demonstrating antioxidant Scientific Reports, 15, 1, 5634, 2025
• Mohammed M Al-Mahadeen, Areej M Jaber, Jalal A Zahra, Belal O Al-Najjar, Mustafa M El-Abadelah, Monther A Khanfar (2024) Discovery and Chemical Exploration of Spiro [Benzofuran-3, 3'-Pyrroles] Derivatives as Innovative FLT3 Inhibitors for Targeting Acute Myeloid Leukemia Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 1,2024
• Moath Alqaraleh, Khaled M Khleifat, Ali Al-Samydai, Belal O Al-Najjar, Fadi G Saqallah, Yaseen T Al Qaisi, Ahmad Z Alsarayreh, Dana A Alqudah, Abdulfattah S Fararjeh (2024) Bioactive potency of extracts from Stylissa carteri and Amphimedon chloros with silver nanoparticles against cancer cell lines and pathogenic bacteria Biomedical Reports, 22,2,34
• Fadi G Saqallah, Belal O Al-Najjar, Aya Y Al-Kabariti, Manal A Abbas (2024) Novel acridone derivatives as potential P2Y12 receptor inhibitors: integrating computational modeling and experimental analysis Journal of Biomolecular Structure and Dynamics, 1-10
• Khaled M Khleifat, Frezah Muhana, Violet Kasabri, Belal Omar Al Najjar, Moath Alqaraleh (2024) Evaluation of the antiproliferative activity and molecular docking of selected branched fatty acids Journal of Medicinal and Pharmaceutical Chemistry Research, 6,9,2024
• Ahmad, Mansour Al-Sayed ; Al-Najjar B.O.; Shakya, Ashok (2024) Novel glucokinase activators: A structure-based pharmacophore modeling, QSAR analysis, and molecular dynamics approach Pharmacia, 71,2024
• Opik Taupiqurrohman, Lathifah Puji Hastuti, Dina Oktavia, Belal Omar Al-Najjar, Muhammad Yusuf, Yani Suryani, Shabarni Gaffar (2024) From fermentation to cancer prevention: The anticancer potential of Kombucha Phytomedicine Plus, 4, 4, 2024
• Adam A Aboalroub, Belal O Al-Najjar (2024) In-silico identification of 3,4-Diarylpyrazoles-based small molecules as potential Hsp90 inhibitors Results in Chemistry, 11,2024
• Ahmed Ismail, Fatma A El-Shibani, Hamdoon A Mohammed, Belal O Al-Najjar, Amany M Korkor, Abdulnaser Kh Abdulkarim, Rana Said, Suliman A Almahmoud, Ghassan M Sulaiman (2024) Chemical composition, antioxidant, and enzyme inhibition activities of Crithmum maritimum essential oils: the first chemo-biological study for species grown Scientific Reports, 14,1,25318
• Hamdoon A Mohammed, Rana Said, Manal M Abbas, Belal O Al-Najjar, Essam Abd-Elmoniem, Riaz A Khan, Abdullah S Alsohim, Suliman A Almahmoud, Taha A Kedra, Safia M Shehata, Ahmed Ismail (2024) Phytochemical, biological, and computational investigations of Ephedra alata Decne. growing in salinity conditions of Arabian Peninsula Scientific Reports, 14, 1, 2024
• Safadi, Wala’a Al.;Al-Najjar, Belal Omar;MoathAlqaraleh,Abed, Anas Ibrahim;Alshaer, Walhan;Alqudah, Dana;Daoud, Fadwa;Obeidat, Razan Mohammad;Sibai, Obada Abdulmalek;Zakaraya, Zainab Zaki (2023) Telmisartan Enhances the Accumulation of Doxorubicin as a Combination Therapy for the Management of Triple Negative Breast Cancer Jordan Journal of Biological Sciences, 16,3,2023
• Abdulwahed, O.A., Al-Najjar, B.O., Abbas, M.A. , Alsalem, M. (2023) Analgesic effect of neohesperidin is mediated by TRPV1 antagonism | El efecto analgésico de la neohesperidina está mediado por el antagonismo TRPV1 Journal of Pharmacy and Pharmacognosy Research, 15,5,2022
• Al-Najjar B.O.; Saqallah, Fadi G. (2023) Unlocking the Conformational Changes of P2Y12: Exploring an Acridinone Compound’s Effect on Receptor Activity and Conformation Molecules, 28,9,2023
• Al-Mahadeen, Mohammed M.; Jaber, Areej M.; Al-Najjar, Belal O. (2023) Design, synthesis and biological evaluation of novel 2-hydroxy-1H-indene-1,3(2H)-dione derivatives as FGFR1 inhibitors Pharmacia, 71,2024
• Belal O Al-Najjar, Manal A Abbas, Obada A Sibai, Fadi G Saqallah, Aya Y Al-Kabariti (2023) QSAR, structure-based pharmacophore modelling and biological evaluation of novel platelet ADP receptor (P2Y 12) antagonist RSC Medicinal Chemistry, 14
• Menier Al-Anazi, Melati Khairuddean, Belal O Al-Najjar, Mohammad Murwih Alidmat, Nik Nur Syazni Nik Mohamed Kamal, Musthahimah Muhamad (2022) Synthesis, anticancer activity and docking studies of pyrazoline and pyrimidine derivatives as potential epidermal growth factor receptor (EGFR) inhibitors Arabian Journal of Chemistry, 7,15,103864
• Mohamed El-Tanani, Arwa Omar Al Khatib, Belal O Al-Najjar, Ashok K Shakya, Yahia El-Tanani, Yin-Fai Lee, Ángel Serrano-Aroca, Vijay Mishra, Yachana Mishra, Alaa A Aljabali, Rohit Goyal, Poonam Negi, Marzieh Ramezani Farani, Maryam Moradi Binabaj, Amir Gholami, Nitin B Charbe, Murtaza M Tambuwala (2022) Cellular and molecular basis of therapeutic approaches to breast cancer Cellular signalling, 110492
• Belal O Al-Najjar, Fadi G Saqallah, Manal A Abbas, Serena Z Al-Hijazeen, Obada A Sibai (2022) P2Y12 antagonists: Approved drugs, potential naturally isolated and synthesised compounds, and related in-silico studies European Journal of Medicinal Chemistry, 227,113924
• Fadi G Saqallah, Abdulsalam Q Almashhadani, Belal O Al-Najjar, Habibah A Wahab (2022) Delavirdine and Dolutegravir as Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro): An In-Silico Study Jordan Journal of Biological Sciences, 15,5
• Sahar Jaffal, Sawsan Oran, Mohammad Alsalem, Belal Al-Najjar (2022) Effect of Arbutus andrachne L. methanolic leaf extract on TRPV1 function: Experimental and molecular docking studies Journal of Applied Pharmaceutical Science, 12,10069-077
• Haitham H Al-Sa’doni, Hamdoon A Mohammed, Belal O Al-Najjar, Hossam H Al-Suod, H Ala’a, Y Esra’a, Alhelal Kafa’AS, Yaseen A Al-Soud (2021) Synthesis, Molecular Docking and Evaluation of Hetaryl Fragment Tagged 1H-1, 2, 4-Triazole Derivatives As Nematicidal Agents Jordan Journal of Chemistry (JJC), 16,1,1-11
• Menier Al-Anazi, Melati Khairuddean, Belal O Al-Najjar, Mohammad Murwih Alidmat, NNSNM Kamal, Musthahimah Muhamad, Maywan Hariono (2021) EGFR Inhibitors and Apoptosis Inducers: Design, Docking, Synthesis, and Anticancer Activity of Novel Tri-Chalcone Derivatives Systematic Reviews in Pharmacy., 12,3,809-820
• Sahar Majdi Jaffal, Belal Omar Al-Najjar, Manal Ahmad Abbas (2021) Ononis spinosa alleviated capsaicin-induced mechanical allodynia in a rat model through transient receptor potential vanilloid 1 modulation The Korean Journal of Pain, 34,3,262-270
• Nurul Hanim Salin, Rahmah Noordin, Belal O Al-Najjar, Ezatul Ezleen Kamarulzaman, Muhammad Hafiznur Yunus, Izzati Zahidah Abdul Karim, Nurul Nadieya Mohd Nasim, Iffah Izzati Zakaria, Habibah A Wahab (2020) Identification of potential dual -targets anti- toxoplasma gondii compounds through structure-based virtual screening and in-vitro studies Plos one, 15,5,e0225232
• Sahar M Jaffal, Belal O Al-Najjar, Manal A Abbas, Sawsan A Oran (2020) Identification of potential dual -targets anti- toxoplasma gondii compounds through structure-based virtual screening and in-vitro studies Plos one, 15,5,e0225232
• Manal Ahmad Abbas, Ghaleb Ali Oriquat, Manal Mohamed Abbas, Belal Omar Al-Najjar, Yasser Ibrahim Kandil (2020) Hypolipidaemic and insulin secretagogue activities of (R)-(−)-Carvone The Malaysian Journal of Medical Sciences: MJMS, 27, 6. 39
• Christophorus Fideluno Adhipandito, Diana Putri Kartika Sari Ludji, Eko Aprilianto, Riris Istighfari Jenie, Belal Al-Najjar, Maywan Hariono (2019) Matrix metalloproteinase9 as the protein target in anti-breast cancer drug discovery: an approach by targeting hemopexin domain Future Journal of Pharmaceutical Sciences, 5,1,1
• Maywan Hariono, Rina F Nuwarda, Muhammad Yusuf, Rollando Rollando, Riris I Jenie, Belal Al-Najjar, Jeffry Julianus, Kevin C Putra, Ervan S Nugroho, Yohanes K Wisnumurti, Sangga P Dewa, Benedictus W Jati, Reynaldo Tiara, Ratna D Ramadani, Lailatul Qodria, Habibah A Wahab (2019) Arylamide as potential selective inhibitor for matrix metalloproteinase 9 (MMP9): design, synthesis, biological evaluation, and molecular modeling Journal of chemical information and modeling, 1,60,349-359
• ahar M Jaffal, Manal A Abbas, Mohammad Alsalem, Belal O Al-Najjar (2019) Evidence for the involvement of opioid receptor in Ajuga chamaepitys action in chemical and thermal models of pain in BALB/c mice Medicinal Chemistry Research, 28,7,992-999
• Sahar Majdi Jaffal and Belal Omar Al-Najjar Manal Ahmad Abbas (2019) Analgesic and Anxiolytic Activities of Achillea Biebersteinii: Evidence for the Involvement of GABAergic Systems Oriental Journal of Chemistry, 35,4,1433-1442
• Belal O Al-Najjar, Ashok K Shakya, Fadi G Saqallah, Rana Said (2018) Pharmacophore modeling and 3D-QSAR studies of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) inhibitors Indian Journal of CHemistry-Section B, 56B, 1200-1206
• Belal O. Al-Najjar (2018) Synthesis, Molecular Docking and Antioxidant Evaluation of Benzylidene Ketone Derivatives Jordan Journal of Biological Sciences , 11, 307-313
• Belal O. Al-Najjar (2018) Investigation of 15-hydroxyprostaglandin dehydrogenase catalytic reaction mechanism by molecular dynamics simulations. Journal of molecular graphics & modelling, 80, 190-196
• Menier Al-Anazi, Belal Al-Najjar, Melati Khairuddean (2018) Structure-Based Drug Design Studies Toward the Discovery of Novel Chalcone Derivatives as Potential Epidermal Growth Factor Receptor (EGFR) Inhibitors Molecules, 23,12,3203
• BO Al-Najjar, AK Shakya, FG Saqallah, R Said (2017) Pharmacophore modeling and 3D-QSAR studies of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) inhibitors Indian Journal of Chemistry, sectionB, 56B, 1200-1206
• Jafar Mohseni, Belal O Al-Najjar, Habibah A Wahab, Z A M H Zabidi-Hussin and Teguh Haryo Sasongko (2016) Transcript, methylation and molecular docking analyses of the effects of HDAC inhibitors, SAHA and Dacinostat, on SMN2 expression in fibroblasts of SMA patients Journal of Human Genetics, 61, 823-830
• Marzieh YaeghoobiNeni Frimayanti,Chin Fei CheeKusaira K. Ikram, Belal O. Al-Najjar, Sharifuddin M. ZainZanariah Abdullah, Habibah A. Wahab, Noorsaadah Abd. Rahman (2016) QSAR, in silico docking and in vitro evaluation of chalcone derivatives as potential inhibitors for H1N1 virus neuraminidase Medicinal Chemistry Research, 25, 10, 2133–2142
• Ashok K Shakya, Avneet Kaur, Belal O Al-Najjar, Rajashri R Naik (2015) Molecular modeling, synthesis, characterization and pharmacological evaluation of benzo[d]oxazole derivatives as non-steroidal anti-inflammatory agents Saudi Pharmaceutical Journal, In press
• Muchtaridi Muchtaridi, Muhammad Yusuf, Ajeng Diantini, Sy Bing Choi, Belal O. Al-Najjar, Jerry V. Manurung, Anas Subarnas, Tri H. Achmad, Savitri R. Wardhani and Habibah A. Wahab. (2014) Potential Activity of Fevicordin-A from Phaleria macrocarpa (Scheff) Boerl. Seeds as Estrogen Receptor Antagonist Based on Cytotoxicity and Molecular Modelling Studies. International Journal of Molecular Sciences, 15(5):7225-49
• (2013) Molecular Dynamics Simulations Predict the Effect of Rosiglitazone Ionisation on PPARγ Activation 5th CADD 2013, Computer-Aided Drug Design Seminar and Workshop,
• Al-Najjar, B. O., Tengku Muhammad, T. S., Wahab, H. A., Rosli, M. M. & Fun, H.-K (2012) 4-(3-Methylbenzenesulfonamido)phenyl 3-methylbenzenesulfonate Acta Crystallographica Section E, 68, o258
• Al-Najjar, B. O., Tengku Muhammad, T. S., Wahab, H. A., Rosli, M. M. & Fun, H.-K. (2012) 4-(4-Fluorobenzenesulfonamido)phenyl 4-fluorobenzenesulfonate Acta Crystallographica Section E, 68, o1094
• Helal, M. H., Al-Mudaris, Z. A., Al-Douh, M. H., Osman, H., Wahab, H. A., Al-Najjar, B. O., Abdallah, H. H. & Abdul Majid, A. M. S. (2012) Diaminobenzene schiff base, a novel class of DNA minor groove binder International Journal of Oncology, 41, 504-510
• Al-Najjar, B. O., Wahab, H. A., Tengku Muhammad, T. S., Shu-Chien, A. C., Ahmad Noruddin, N. A. & Taha, M. O. (2011) Discovery of new nanomolar peroxisome proliferator-activated receptor γ activators via elaborate ligand-based modeling European Journal of Medicinal Chemistry, 46, 2513-2529
• Tran, L., Choi, S. B., Al-Najjar, B. O., Yusuf, M., Wahab, H. A. & Le, L (2011) Discovery of Potential M2 Channel Inhibitors Based on the Amantadine Scaffold via Virtual Screening and Pharmacophore Modeling Molecules, 16, 10227-10255
• Habibah A.Wahab, Nornisah Mohamed, Rashidah A.Rahim, and Belal Omar Alnajjar (2006) Natural Flavonoids for the treatment of hyperurecemia, Molecular docking and crystallography studies. FMBE Proceedings , 14, pp 178-182

الكتب المنشورة:

• First-Pass Metabolism Considerations in Pharmaceutical Product Development (2018) Dosage Form Design Considerations Academic Press
• (2018) First-Pass Metabolism Considerations in Pharmaceutical Product Development Academic Press